Table 2 Association of circadian rest-activity metrics and incident frailty with adjustment for covariates
From: Circadian disturbances and frailty risk in older adults
HR (95%CI) p value | HR (95%CI) p value | HR (95%CI) p value | HR (95%CI) p value | HR (95%CI) p value | HR (95%CI) p value | HR (95%CI) p value | |
---|---|---|---|---|---|---|---|
Agea | 1.09 (1.07–1.11) < 0.001 | 1.09 (1.07–1.11) < 0.001 | 1.09 (1.07–1.12) < 0.001 | 1.10 (1.08–1.12) < 0.001 | 1.09 (1.07–1.11) < 0.001 | 1.09 (1.07–1.11) < 0.001 | 1.09 (1.07-1.11) < 0.001 |
Female sex | 3.83 (2.65–5.53) < 0.001 | 3.47 (2.42–4.99) < 0.001 | 3.81 (2.63–5.51) < 0.001 | 3.65 (2.54–5.25) < 0.001 | 3.76 (2.60–5.42) < 0.001 | 3.86 (2.68–5.57) < 0.001 | 3.35 (2.33-4.83) < 0.001 |
Educationb | 1.06 (1.02–1.11) 0.004 | 1.05 (1.00–1.09) 0.030 | 1.05 (1.01–1.09) 0.020 | 1.05 (1.01–1.10) 0.012 | 1.05 (1.01–1.10) 0.012 | 1.06 (1.01–1.10) 0.008 | 1.05 (1.00-1.09) 0.029 |
Sleep durationa | 1.03 (0.92–1.16) 0.558 | 1.05 (0.94–1.17) 0.403 | 1.07 (0.95–1.19) 0.255 | 1.06 (0.95–1.18) 0.333 | 1.02 (0.91–1.14) 0.766 | 1.07 (0.95–1.21) 0.283 | 1.12 (0.98-1.29) 0.085 |
Sleep fragmentationc | 1.16 (1.00–1.35) 0.050 | 1.17 (1.01–1.36) 0.034 | 1.18 (1.02–1.37) 0.024 | 1.19 (1.03–1.37) 0.021 | 1.15 (0.99–1.33) 0.072 | 1.12 (0.97–1.30) 0.127 | 1.20 (1.03-1.39) 0.016 |
Vascular disease burden | 1.14 (0.96–1.34) 0.132 | 1.22 (1.04–1.44) 0.016 | 1.16 (0.98–1.37) 0.076 | 1.17 (0.99–1.38) 0.058 | 1.19 (1.01–1.40) 0.035 | 1.15 (0.98–1.36) 0.092 | 1.21 (1.03-1.42) 0.023 |
Vascular risk factors | 1.24 (1.07–1.44) 0.005 | 1.24 (1.07–1.45) 0.005 | 1.25 (1.08–1.46) 0.003 | 1.27 (1.09–1.47) 0.002 | 1.25 (1.08–1.45) 0.003 | 1.22 (1.05–1.41) 0.011 | 1.25 (1.07-1.45) 0.004 |
Amplituded | 1.37 (1.21–1.56) < 0.001 | ||||||
Acrophased | 1.04 (0.93–1.17) 0.489 | ||||||
Variation of cycle lengthc | 1.28 (1.14–1.44) < 0.001 | ||||||
ISd | 1.27 (1.13–1.43) < 0.001 | ||||||
IVc | 1.21 (1.07–1.38) 0.003 | ||||||
M10d | 1.41 (1.20–1.64) < 0.001 | ||||||
L5c | 1.15 (0.99-1.33) 0.063 |